Scholars Central

PerspectivePublished 22 Jul 2016

Bioresorbable stents for pediatric practice: where are we now?

Authors: D Kenny, ZM Hijazi

Interventional Cardiology

Volume 7 · Issue 3 · Pages 245–256

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Children born with congenital heart disease may outgrow materials used to palliate their heart defects. Application of evolving bioresorbable technologies to these children may assist in providing minimally invasive options that lead to restoration of vascular function, arterial remodeling and vessel growth. The availability of this technology for children may be even more vital than its use in adults as early reversal of vessel stenosis in children may have a profound impact on lifetime vessel development, and the disappearance of the scaffold over time ensures that somatic development should not lead to stent outgrowth. This review evaluates the progress of bioresorbable scaffold development as applied to children with congenital heart disease.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInterventional Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “D Kenny”
  • BylineArticles whose byline prints “ZM Hijazi”